Page 9 - Diagnosis and clinical consequences of cachexia in patients with advanced cancer Susanne Blauwhoff-Buskermolen

Contents
Chapter 1 Chapter 2
Chapter 3
Chapter 4 Chapter 5 Chapter 6 Chapter 7 Chapter 8
Chapter 9
General introduction 9
Letter to the Editor ‘Precachexia’: a non-existing 21 phenomenon in cancer?
Weight loss of 5% or more predicts loss of fat free mass 27 during palliative chemotherapy in patients with advanced
cancer – a pilot study
The assessment of anorexia in patients with cancer : cut- 45 off values for the FAACT–A/CS and the VAS for appetite
Plasma ghrelin levels are associated with anorexia but not 57 cachexia in patients with NSCLC
The in uence of different muscle mass measurements on 67 the diagnosis of cancer cachexia
Higher muscle strength is associated with prolonged 85 survival in older patients with advanced cancer
Loss of muscle mass during chemotherapy is predictive for 101 poor survival of patients with metastatic colorectal cancer
Letter to the Editor 116
Response from the authors 119
The effect of individualized NUTritional counseling on 123 muscle mass and treatment outcome in patients with
metastatic COLOrectal cancer undergoing chemotherapy:
a randomized controlled trial protocol
Chapter 10
Summar y
Samenvatting
Dankwoord
About the author 165 Publications 166
General discussion 139 152 156 160